Enrico Sangiorgio - Surgalign Holdings Ex International
Insider
Enrico Sangiorgio is Ex International of Surgalign Holdings
| Age | 47 |
| Phone | 224 303 4651 |
| Web | https://www.surgalign.com |
Enrico Sangiorgio Latest Insider Activity
Tracking and analyzing the buying and selling activities of Enrico Sangiorgio against Surgalign Holdings stock is an integral part of due diligence when investing in Surgalign Holdings. Enrico Sangiorgio insider activity provides valuable insight into whether Surgalign Holdings is net buyers or sellers over its current business cycle. Note, Surgalign Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell Surgalign Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Enrico Sangiorgio over a year ago Payment of 209 shares by Enrico Sangiorgio of Surgalign Holdings subject to Rule 16b-3 |
Surgalign Holdings Management Efficiency
The company has return on total asset (ROA) of (0.3494) % which means that it has lost $0.3494 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (14.9702) %, meaning that it created substantial loss on money invested by shareholders. Surgalign Holdings' management efficiency ratios could be used to measure how well Surgalign Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Surgalign Holdings currently holds 10.19 M in liabilities with Debt to Equity (D/E) ratio of 0.54, which is about average as compared to similar companies. Surgalign Holdings has a current ratio of 2.28, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Surgalign Holdings' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Lawrence Mertz | Accelerate Diagnostics | 62 | |
| Alok Gupta | Hyperfine | 58 | |
| Ryan Sabia | Tivic Health Systems | 37 | |
| Laura Pierson | Accelerate Diagnostics | N/A | |
| Michelle Scharfenberg | Avanos Medical | N/A | |
| Miguel BeltranDelgado | Bioventus | N/A | |
| Michelle Missal | Paragon 28 | N/A | |
| Heather Brennan | Establishment Labs Holdings | N/A | |
| Joseph Powers | Si Bone | 64 | |
| Blake Gurfein | Tivic Health Systems | 41 | |
| Robert Carlson | Biomerica | N/A | |
| Matt Jarboe | Paragon 28 | N/A | |
| B Johnson | Paragon 28 | 68 | |
| Katrina Church | Bioventus | 62 | |
| Steven Sloan | Biomerica | 54 | |
| Meghan Scanlon | Paragon 28 | 48 | |
| Sanjay Ahuja | Tivic Health Systems | N/A | |
| John Meduri | Accelerate Diagnostics | N/A | |
| Brendan Shook | Paragon 28 | N/A | |
| Tyla Bucher | Movano Inc | N/A | |
| Paul Verrastro | CVRx Inc | 62 | |
Management Performance
| Return On Equity | -14.97 | |||
| Return On Asset | -0.35 |
Surgalign Holdings Leadership Team
Elected by the shareholders, the Surgalign Holdings' board of directors comprises two types of representatives: Surgalign Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Surgalign. The board's role is to monitor Surgalign Holdings' management team and ensure that shareholders' interests are well served. Surgalign Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Surgalign Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Thunander, VP Officer | ||
| William Durall, Chief Officer | ||
| Enrico Sangiorgio, Ex International | ||
| David Lyle, Chief Officer | ||
| Suzanne Zoumaras, Chief Officer | ||
| Olivier Visa, Pres OEM | ||
| Paolo Amoruso, Gen Officer | ||
| Terry Rich, CEO Pres | ||
| Bob Watkins, Chief Officer | ||
| John Varela, Ex Operations |
Surgalign Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Surgalign Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -14.97 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (0.65) % | |||
| Operating Margin | (0.68) % | |||
| Current Valuation | (7.93 M) | |||
| Shares Outstanding | 9.18 M | |||
| Shares Owned By Insiders | 17.15 % | |||
| Shares Owned By Institutions | 23.05 % | |||
| Number Of Shares Shorted | 65.91 K | |||
| Price To Book | 1.79 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Surgalign Stock
If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |